BDBM385917 US10287292, Compound 1.095::US11059825, Compound 1.095

SMILES Fc1ccc(cc1)-c1nc(co1)C(=O)N[C@H]1CCN(C1)c1nccn2cccc12

InChI Key InChIKey=ZTGOWADAFHTBMV-INIZCTEOSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 385917   

TargetAtypical chemokine receptor 3(Homo sapiens (Human))
Chemocentryx

US Patent
LigandPNGBDBM385917(US10287292, Compound 1.095 | US11059825, Compound ...)
Affinity DataIC50: <500nMAssay Description:Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAtypical chemokine receptor 3(Homo sapiens (Human))
Chemocentryx

US Patent
LigandPNGBDBM385917(US10287292, Compound 1.095 | US11059825, Compound ...)
Affinity DataIC50: <500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAtypical chemokine receptor 3(Homo sapiens (Human))
Chemocentryx

US Patent
LigandPNGBDBM385917(US10287292, Compound 1.095 | US11059825, Compound ...)
Affinity DataIC50: <500nMAssay Description:Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAtypical chemokine receptor 3(Homo sapiens (Human))
Chemocentryx

US Patent
LigandPNGBDBM385917(US10287292, Compound 1.095 | US11059825, Compound ...)
Affinity DataIC50: <500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent